Using a clinical trial recruitment company doesn’t have to be a last-ditch effort — it can actually help sponsors save time and money from the beginning.

Clinical trial matching software can benefit sponsors and patients by streamlining the process of searching for research studies.

Antidote’s latest whitepaper shares insights from our database about obesity and clinical trials.

Several barriers have slowed COPD research in the past and continue to present challenges for researchers today.

Endometrial cancer is extremely common, so there are several facts that are important to note about the condition.

Emily Schaller, founder and CEO of the Rock CF Foundation, talked with Antidote about her experience participating in clinical trials for cystic fibrosis.

Learn more about how IWRS works and how to choose the right system for your clinical trial's needs.

IgA nephropathy is a type of renal disease that currently has no known treatment — but research is underway to understand it more.

C3G is a rare type of kidney disease with no FDA-approved treatment — but researchers are working to better understand how to help patients.

By surveying patients through our partner network, we’re able to better understand the relationship that people have to clinical trials.

A recent survey Antidote conducted with partners reveals how to increase diversity in clinical research.

View Antidote's webinar where we discuss how to find inclusive solutions to patient recruitment for obesity clinical trials.